Zydus

Zydus Lifesciences reports impressive 53.2% rise in Q2 net profit

Indian pharmaceutical company Zydus Lifesciences posted robust financial results for the July-September quarter of the fiscal year 2023-2024.

Zydus Wellness: Check out all the FY- 23 Q4 highlights

On Wednesday, Zydus Wellness, an Indian consumer goods firm that makes skincare and nutrition products, announced its quarterly results.

Zydus receives EIR with VAI from USFDA

Zydus Lifesciences Q4 net income drops 24% to Rs 397 crore

Zydus Lifesciences Ltd. reported a net profit of Rs 397.4 crore for the fourth quarter ended March 31, 2022 of financial year 2021-22, owing to development in the domestic and emerging markets formulations operations (FY22).

DCGI aprroves use of Zydus’s Virafin in treating moderate COVID-19 infection

Zydus Cadila has received emergency use approval from the Drugs Controller General of India (DCGI) on Friday in treating moderate COVID-19 infection.